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ABSTRACT

Introduction: Esophageal cancer rates are increasing rapidly. Major morbidity and
mortality rates continue to be quite high in large series of trans-thoracic esophagectomies.
Minimally invasive approaches to esophagectomy are increasingly being utilized. We
compare our growing series of minimally-invasive (combined thoracoscopic and
laparoscopic) esophagectomies (MIE) to a contemporary series of open, trans-thoracic
esophagectomy.
Methods: We queried a prospectively maintained IRB-approved esophagectomy database
at Thomas Jefferson University Hospital to identify 65 patients who underwent a MIE
with only a thoracoscopic component (n=11), or minimally-invasive Ivor Lewis approach
(n=2), or minimally-invasive three-hole approach (true MIE, n=52). The majority of
these were performed in the last 18 months. These patients were compared to a group of
53 patients who underwent open Ivor-Lewis esophagectomy (n=15) or open three-hole
esophagectomy (n=38) over the last 10 years. Perioperative complications were graded
using a variation of the Clavien scale.
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Results: The MIE and open groups were similar in terms of gender (75% male in both
groups) and average age (61 vs. 62 years, respectively). The majority of patients in the
open group underwent neoadjuvant chemoradiation therapy (81%) due to institutional
preferences at the time; a significantly smaller (43%) number of patients in the MIE
group underwent neoadjuvant therapy (p<0.0001). In terms of oncologic efficacy, 97%
and 94% of patients in both groups underwent R0 resections. Patients undergoing MIE
had a significant increase in the number of harvested LN (median=20 vs. 9 nodes,
p<0.0001). Pathologic stage was similar between both groups. Length of stay was
significantly decreased in patients who underwent MIE (8.5 days vs. 16 days, p=0.002).
Finally, there were significantly fewer serious complications (grades 3-5) in the MIE
group (19% vs. 48%, p=0.0008).
Conclusions: In this initial report of a growing single-institution series of MIE, we
demonstrate that oncologic efficacy, in terms of completeness of resection and number of
harvest LN is not compromised with this approach, and may actually be improved with a
significantly increased number of harvested LNs. We also demonstrate this approach is
associated with fewer serious complications and significant decrease in the length of
postoperative hospital stay.
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INTRODUCTION
Esophageal cancer is the eighth most common cause of cancer worldwide 3. In
2010, it is estimated that there will be 16,640 new cases diagnosed in the U.S. and 14,500
deaths 1. It often presents at an advanced stage and therefore tends to be incurable. For
resectable disease, surgery is the gold standard for treatment. For these patients, who
often have considerable co-morbid conditions (obesity, smoking, and diabetes),
esophagectomy carries a significant risk of perioperative morbidity and mortality.
Mortality rates range from 5-20% 2,3and morbidity generally occurs in approximately
50% of patients 3. Many series also report higher rates of complications with transthoracic esophagectomy compared to transhiatal esophagectomy 4.
The minimally invasive approach to esophagectomy was first reported by
Cuschieri et al in 1992 5. Since that time, numerous reports have shown that the
procedure is safe, feasible, and leads to a favorable outcome for a number of early
operative variables when compared to open esophagectomy 6,7, 8. Additional small series
have demonstrated that lymph node retrieval is adequate with MIE 9and in most cases
comparable to that seen with open procedures 10.
The minimally invasive approach to esosphagectomy encompasses three main
approaches: (1) laparoscopic transhiatal esophagectomy with anastomosis in the neck, (2)
laparoscopic and thoracoscopic Ivor-Lewis esophagectomy, and finally (3) laparoscopic
and thoracoscopic three-hole esophagectomy with the anastomosis in the neck (true
MIE). There are various other combinations, and early in our experience, we performed
the abdominal portion open but the thoracic portions were performed with Video Assisted
Thoracoscopic Surgery (VATS). Because many series have demonstrated the morbidity

4

of the open trans-thoracic component, we believe that performing the thoracic portion
with VATS provides a substantial benefit. At Thomas Jefferson University Hospital, we
have been attempting MIE in all patients since July 2008. We have performed all three of
the above-mentioned methods, but the majority are true MIE. This report is our initial
analysis of our experience with thoracoscopic and laparoscopic MIE with particular focus
on the oncologic efficacy as demonstrated by lymph node retrieval and completeness of
resection.

METHODS
Patient Population
We queried our IRB-approved prospective esophagectomy database for patients
undergoing esophagectomy for cancer or high-grade dysplasia between 2000 and October
2010. Data collected included type of esophagectomy, age, gender, race, neoadjuvant
chemoradiation, history of smoking, completeness of resection, histologic diagnosis,
pathologic stage, total number of harvested lymph nodes, length of stay, and
perioperative complications. Complications were graded on a scale of 1-5 using a
modification of the previous published scale of Clavien et al 11. Any patient with a
VATS component that was completed thoracoscopically was included in the analysis
because of the known benefits of avoiding a thoracotomy. Patients undergoing surgery
with biopsies revealing high-grade dysplasia were also included in this analysis because
these patients were treated as if they had cancer because of the high incidence of invasive
cancer seen in those who undergo definitive surgery. The breakdown of cases included in
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the minimally invasive groups is as follows: VATS/laparotomy/neck incision—eleven
cases; VATS/Laparoscopy/Ivor-Lewis—two cases; and VATS/laparoscopy/neck
incision—52 cases for a total of 65 cases minimally invasive cases.
The database was then queried in an attempt to find a contemporary (after 2000)
cohort of patients who underwent esophagectomy with a thoracotomy component. We
identified a total of 53 open cases that met these criteria. Similar data were collected in
these patients—Ivor-Lewis (n=15) and 3-Hole (n=38). Continuous variables (such as
age, length of stay, and total number of lymph nodes (LN) harvested) were compared
using Student’s t-test. Categorical variables (such as complication grade) were compared
using Chi-square. Statistical significance was accepted at p<0.05.

Surgical Technique for ‘3-hole’ MIE
Thoracoscopic Portion
The patient is placed in the right lateral decubitus position. The following ports
are typically placed: 1) at the anterior axillary line in the 8th intercostal space (10 mm
port); 2) at the posterior axillary line in the 7th intercostal space (10 mm); 3) below the tip
of the scapula (5 mm); 4) 4th intercostal space in the anterior axillary line (10 mm); and
5) between the 1st and the 4th ports for suction (5 mm). An Endo Stitch is placed at the
tendinous portion of the right diaphragm. This is brought through the skin using a CarterThompson device and maintained on tension to retract the diaphragm. The dissection
starts anteriorly at the pericardium. The harmonic scalpel is used to incise the pleura and
separate the periesophageal fat from the pericardium. The subcarinal lymph node package
is then completely removed, separating it carefully from the left and right main stem
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bronchi. The azygous vein is divided with an Endo GIA using a vascular load. Nodal
tissue around the esophagus is dissected and brought with the specimen. The esophagus is
then carefully separated from the trachea and the dissection then proceeds cephalad to the
thoracic inlet. The pleura, posteriorly, is then incised anterior to the thoracic duct. The
esophagus and periesophageal tissue are dissected away from the aorta; aortoesophageal
branches are clipped and divided. An intercostal block with Marcaine is performed at the
level of ribs 6, 7, 8, and 9, and a single chest tube is inserted.
Laparoscopy
The patient is then repositioned in the relaxed lithotomy position. A
transumbilical approach is used for insertion of the 12 mm camera port. The remaining 5mm ports are placed in the right lateral subcostal position and the left subcostal position.
A mid-axillary 12-mm port is inserted in the right subcostal position. Using these ports,
the greater curvature of the stomach is mobilized, with fastidious preservation of the
gastroepiploic arcade. The short gastric vessels are divided and the fundus is mobilized.
The greater omentum is divided along the gastroepiploic arcade and the stomach is
completely mobilized down to the origin of the right gastroepiploic arterial system. The
lesser curve is then mobilized and the right diaphragmatic crus identified. The
phrenoesophageal ligament is incised and the retrocardia space is established. The right
crus is opened by incising it with the Harmonic scalpel to allow for easy placement of the
conduit. At this point, the left gastric artery is divided with the endovascular GIA stapler,
and the nodal tissue is swept up with the specimen. Next, the 12 mm port site is enlarged
to an approximately 5 cm incision and a Lap Disk wound protector is inserted.
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Neck incision and completion
The left neck is approached through an oblique incision paralleling the anterior
border of the sternocleidomastoid. The platysma and strap muscles are divided as is the
inferior thyroid artery. The left recurrent largyngeal nerve is identified and preserved
throughout its course. The esophagus is then encircled and transected with a GIA-75
linear cutting stapler. The distal end of the divided esophagus is attached to a chest tube
as a mediastinal placeholder and delivered with the stomach through the wound protector
in the right upper quadrant small incision. The stomach is tubularized extracorporeally
with a GIA-75 stapler and the suture line is oversewn with a running 3-0 PDS suture. A
pyloromyotomy is also performed through this incision. The proximal tip of the stomach
tube is then attached to the mediastinal chest tube placeholder and the stomach, in proper
orientation, is delivered back up into the left neck, where a side-to-side
esophagogastrostomy anastomosis is performed with an Endo GIA stapler. The
nasogastric tube is positioned through this anastomosis. The anastomosis is then
completed with a TA-60 stapler. A tacking suture is then placed from the staple line to
the prevertebral fascia to keep this anastomosis in the neck region. At this point, a #14
French red rubber catheter is placed laparoscopically as a feeding jejunostomy tube.
Synopsis of surgical technique for Ivor-Lewis MIE
The operation is begun with the patient in relaxed lithotomy position and the
laparoscopic portion is performed as above. At the completion, the conduit is placed back
into the abdominal cavity in the correct orientation so that it can be delivered into the
chest for the next portion. The patient is then placed in the right lateral decubitus position
and VATS ports are placed as above. The dissection proceeds as previously described
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except for that done towards the thoracic inlet. Once the esophagus is dissected
circumferentially to the level of the azygous vein, it is sharply divided at this level and
removed through a slightly enlarged posterior surgeon’s port (#2, above).
At this point, a 29 EEA anvil is placed inside the esophagus. An EndoStitch is
used to create a pursestring to secure the anvil in the esophageal lumen. The conduit is
grasped and opened so that the EEA shaft can be placed into it. The spike from the
EEA is brought out from the side of the conduit and docked into the anvil. The EEA is
then fired and removed. At this point, an Endo GIA blue load is used to amputate that tip
of the stomach and remove it from the chest. Another EndoStitch is used to tack the
stomach to the diaphragmatic crura. The intercostal nerve block and chest tube placement
proceed as described above.

RESULTS
Demographics (Table 1)
The groups were relatively equally matched in terms of demographic data (Table
1). The average age in the open group was slightly higher at 62 years although this was
not a significant difference (p=0.6). The majority of patients in both groups were male.
Finally, the vast majority of patients in the minimally invasive group (94%) had
adenocarcinoma (n=55) or high-grade dysplasia (n=5), which reflects recent trends at
TJUH where it is rare to see a patient with squamous cell carcinoma of the esophagus and
even rarer for them to undergo esophagectomy. There were significantly more patients in
open group who underwent neoadjuvant chemoradiation (81% vs. 43%). Finally, the
patients were well distributed by pathologic stage—about 30% of patients in both groups
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had a stage 0 tumor. The majority of these were patients who had pathologic complete
response to neoadjuvant chemoradiation.
Type of Surgery
In the minimally invasive group (n=65), there were eleven patients who
underwent VATS with laparotomy and an anastomosis in the neck. Some of these
patients were early in our experience (most in 2004 and 2005). There were also five
patients who were intended to have MIE but the abdominal portion was unable to be
completed laparoscopically due to severe adhesions from previous abdominal surgery.
The majority of patients in the MIE group (n=52) underwent both a thoracoscopic and a
laparoscopic component with the esophagogastric anastomosis being performed in the
neck. Two patients had the thoracoscopic/laparoscopic components with Ivor-Lewis type
anastomosis.
In the open group, we chose for comparison a group of patients who underwent a
thoracotomy as part of their esophagectomy. These patients stretched back to 2000,
because the majority of recent cases are being done without a thoracotomy. In total, there
were 15 patients who underwent Ivor-Lewis esophagectomy with an anastomosis in the
chest and 38 patients who underwent 3-hole esophagectomy with an anastomosis in the
neck. In the same time period, there were no other trans-thoracic esophagectomies and
there were 76 open, transhiatal esophagectomies. Figure 1 demonstrates the overall
volume and surgical trends at TJUH from 2000 to 2010. There were no major differences
in perioperative variables for patients in either of the open groups in terms of blood loss,
length of stay and nodal yields.
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Perioperative Complications (Table 2)
There were five perioperative deaths (8%) in the MIE and four (8%) in the open
group. This difference was not statistically significant. Of the five deaths in the MIE
cohort, one was a sudden, unexplained, death on post-operative day one; the other four
patients developed pneumonia and respiratory failure, which led to their demise. Of these
five deaths in the MIE cohort, there were three deaths in the laparoscopy/thoracoscopy
group (6%) and two deaths in the thoracoscopy/laparotomy group (18%). In the open
group, the four patients who died suffered from gastric conduit necrosis, ischemic bowel,
ARDS, and pneumonia/respiratory failure (one each). In terms of overall complications
(Table 2), the rate was slightly higher in the open group (60% vs. 48%, p=0.1). We did
find a significantly higher rate of major complications (grades 3 and above) in the open
group (41% vs. 20%). As expected, there was a higher rate of pneumonia in the open
group (18%), and only 7.7% in the MIE group, but this difference was not statistically
significant. There were two major complication rates which were significantly higher in
the open group. The rate of respiratory failure and ARDS in the open group (21%) was
significantly higher than that observed in the MIE cohort (7.7%, p=0.03). Additionally
the 11% rate of DVT/PE in the open group was significantly increased compared to the
1.5% seen in the MIE group (p=0.04). The rate of anastomotic leaks was equal in both
groups. The most common minor complications were wound infections and
supraventricular arrhythmia; there were no significant differences between groups for
these minor complications.
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Surgical Outcomes (Table 3)
The average blood loss was significantly lower for patients who underwent MIE
as compared to those who had open surgery (182 vs. 619ml, p<0.0001). Additionally, the
median length of stay (9 vs. 16 days) was significantly less in patients who underwent the
minimally invasive approach (p=0.003). The R0 resection rates were high in both
groups, and there were no differences between the groups. All five of the R1 resections
consisted of the circumferential margins being positive and not margins on the esophagus
or stomach themselves. Finally, we did note a significant increase in nodal harvest in the
MIE group (median-20 vs. 9, p<0.0001).

DISCUSSION
Since its first description in 1992, minimally invasive esophagectomy (MIE) has
become more and more prevalent with numerous reports of large series appearing in the
literature. In a recent review from England, Lazzarino et al demonstrate that the
percentage of minimally invasive esophagectomies being performed there has increased
from 0.6% in 1996/1997 to 16% in 2007/2008 6. With the increasing frequency of this
operation, it is incumbent on investigators to ensure that not only is this operation safe
but that the oncologic outcomes are equivalent to that of the open operation.
When laparoscopic colectomy for cancer was first introduced, there was a concern
about port-site recurrences and oncologic efficacy 12,13. However, several randomized
prospective trials demonstrated that the laparoscopic approach was not only safe, but
oncologically sound. The COST trial (n=872) demonstrated equivalent nodal yields,
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recurrence-free, and overall survival with shorter hospital stay and decreased narcotic use
in patients with colon cancer 14. The COLOR trial from Europe (n=1248) also
demonstrated equivalent nodal yields and margin positive resections 15. Finally, in an
analysis of NSQIP data, Bilimoria et al demonstrated that laparoscopic colectomy was
associated with a significantly decreased rate of any complication and length of stay 16.
In retrospect, early concerns about port-site recurrences and oncologic efficacy now
appear unfounded.
There have been many small institutional series that have compared MIE with
open, trans-thoracic approaches. In a group of 90 patients undergoing MIE or Ivor-Lewis
esophagectomy, Pham et al showed that MIE was associated with decreased blood loss
and rates of wound infection, but no change in length of stay and cardiovascular and
pulmonary complications 7. They also demonstrated a significant increase in nodal yield
with MIE (13 vs. 8). Parameswaran et al also compared MIE and Ivor-Lewis
esophagectomy in a series of 80 patients. They demonstrated an increased rate of
pulmonary complications in the open group (23% vs. 8%). Interestingly, they also
demonstrated that nodal yields were significantly higher in the MIE cohort (23 vs. 10) 17.
Finally, in a recent meta-analysis, Nagpal et al reviewed 12 studies of 672 patients
undergoing MIE and 612 open esophagectomies. This analysis demonstrated that MIE
had lower blood loss, shorter hospital stay, and reduced total morbidity and respiratory
complications 8.
The current series is one of the largest reported in which MIE is compared to open
esophagectomy in a single-institution series. We acknowledge that there are several
limitations of our series. First of all, because our current practice is to attempt MIE in
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virtually every patient, we cannot use a concurrent series of patients for comparison, and
instead had to use historical data and attempt to match patients as best as possible.
Additionally, this is not a randomized, prospective trial comparing the open technique to
MIE. We compared patients undergoing esophagectomy with a thoracoscopic
component (eleven with VATS/laparotomy, 52 true MIE, and two MIE/Ivor-Lewis) to
those undergoing esophagectomy with an open thoracotomy (15 Ivor-Lewis and 38 threehole esophagectomies). We confirm many of the findings of the previous series and metaanalyses. Specifically, we demonstrate a significant decrease in major complications for
patients undergoing MIE compared to open, trans-thoracic approaches, including
decreased incidence of pneumonia, respiratory failure and ARDS. We also demonstrate
that blood loss and length of stay are significantly decreased with the minimally invasive
approach. Most importantly, we show that R0 resection rates are equal and that lymph
node yield is significantly higher as compared to open approaches.
The importance of lymph node yield in numerous cancers is increasingly being
demonstrated in numerous gastrointestinal cancers including esophageal cancer 18,19. It is
interesting to speculate why lymph node yields are increased in minimally invasive
approaches in not only our series but two others as well 7,17. It is likely that this is multifactorial and has to do not only with improved processing on the part of pathology
departments, with increased awareness of importance of nodal yields, but also
improvements in operative technique. Pham et al state that their technique has evolved to
include more complete clearance of the celiac node basin 7. In our thoracoscopic
approach, we specifically clear the level 7, 8, and 9 mediastinal nodes. Also, the
laparoscopic approach affords a better dissection of the celiac nodes and removal of left
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gastric nodes by allowing better visualization and the ability to divide the left gastric
artery at its origin with the vascular stapler.
It remains to be seen whether this increased nodal yield will result in a survival
benefit because the majority of our patients who underwent MIE were operated on in the
last 18 months. In one of the earlier randomized trials of laparoscopic colectomy, Lacy et
al, demonstrated that cancer-specific survival was significantly higher in the laparoscopic
group (91% vs. 79%). This benefit was limited almost exclusively to patients with stage
III disease 20. This benefit was not redemonstrated in other larger randomized series.
Additionally, in Lazzarino’s analysis of MIE in the United Kingdom, there was a
suggestion that patients undergoing MIE had better 1-year survival rates than patients
undergoing open esophagectomy 6.
Therefore, in conclusion, we demonstrate that minimally invasive approaches to
esophagectomy offer several advantages over open ones. These include decreases in the
number of major complications, respiratory complications, blood loss and length of stay.
At the same time, oncologic efficacy is maintained with equivalent R0 resection rates,
and significantly increased nodal yields. It is our feeling that the minimally invasive
approach is justified for patients with esophageal cancer, and is safe even in patients who
have received neoadjuvant therapy. Future study will need to determine the impact of
these approaches on survival.
.
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TABLES
Table 1—Patient Demographics and Pathology
Minimally Invasive

Open (n=53)

p-value

41-78 (mean=61)

40-86 (mean=62)

0.6

Gender (#male)

51 (78%)

38 (72%)

0.5

Caucasian

55 (85%)

51 (96%)

0.06

Neoadjuvant therapy

28 (43%)

43 (81%)

<0.0001

Adenocarcinoma

55 (85%)

39 (74%)

0.2

Squamous cell carcinoma

4 (6%)

14 (26%)

0.004

High-grade dysplasia

5* (8%)

0

0.06

0

18 (28%)

17 (32%)

0.7

I

24 (37%)

12 (23%)

0.1

II

10 (15%)

12 (23%)

0.3

III

13 (20%)

10 (19%)

1.0

IV

0

2 (4%)

0.2

(n=65)
Age

Pathologic Stage

* one patient underwent MIE for esophageal melanoma.
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TABLE 2
Minimally Invasive (n=65)

Open (n=53)

p-value

Mortality

5 (7.7%)

4 (7.5%)

1.0

Overall Complications

31 (48%)

32 (60%)

0.1

Major Complications

13 (20%)

23 (41%)

0.008

18 (28%)

12 (23%)

0.5

5 (7.7%)

12 (21%)

0.03

Pneumonia

5 (7.7%)

10 (18%)

0.11

Anastomotic Leak

9 (14%)

6 (11%)

1.0

DVT/PE

1 (1.5%)

6 (11%)

0.04

(Grades 3-5)
Minor Complications
(Grades 1-2)
Respiratory Failure/
ARDS

DVT—deep venous thrombosis
PE—pulmonary embolism
ARDS—adult respiratory distress syndrome
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TABLE 3
Minimally Invasive (n=65)

Open (n=53)

p-value

Mean EBL (ml)

182

619

<0.0001

Median LOS (days)

9

16

0.003

R0 Resection

63 (97%)

50 (94%)

0.6

Median # harvested

20

9

<0.0001

LN
EBL-estimated blood loss
LOS—length of stay
LN—lymph nodes
R0—margins microscopically negative
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